Literature DB >> 30115298

Analysis of cases and accuracy of 3 risk scoring systems in predicting ectasia after laser in situ keratomileusis.

Cordelia Chan1, Alain Saad1, J Bradley Randleman1, Mona Harissi-Dagher1, Daniel Chua1, Mujtaba Qazi1, Jean-Jacques Saragoussi1, Rohit Shetty1, Jean-Marc Ancel1, Robert Ang1, Dan Z Reinstein1, Damien Gatinel2.   

Abstract

PURPOSE: To identify risk factors for ectasia after laser in situ keratomileusis (LASIK) by comparing the accuracy of the Ectasia Risk Score System (ERSS), Screening Corneal Objective Risk of Ectasia (SCORE) Analyzer, and percentage of tissue altered (PTA) in predicting the occurrence of ectasia.
SETTING: Multiple centers in 8 countries.
DESIGN: Retrospective case series.
METHODS: Previously unpublished post-LASIK ectasia cases were analyzed. Consecutive patients who had LASIK performed at least 5 years previously with no resultant ectasia were used as controls. Axial maps from preoperative Orbscan IIz topographies were analyzed in a masked fashion, and examination files tested with the SCORE Analyzer. The PTA values and ERSS scores were generated using available preoperative and perioperative data. Only eyes with subjectively identified normal preoperative topography were tested with the PTA. Threshold values for the SCORE, ERSS, and PTA were more than or equal to 0, 4, and 40, respectively.
RESULTS: Ectasia occurred in 31 eyes (22 patients); 79 eyes (44 patients) were used as controls. In all eyes, the sensitivity and specificity for predicting ectasia, respectively, were 67.7% and 79.7% for the ERSS and 64.5% and 100% for the SCORE. In eyes with normal topography (ectasia group, 12 eyes; controls, 64 eyes), the PTA yielded sensitivity of 33.3% and specificity of 85.9%. The area under the receiver operating characteristic curve was highest for SCORE (0.911) followed by the ERSS (0.844) and PTA (0.557).
CONCLUSIONS: The SCORE was most predictive of ectasia, achieving the best specificity; the ERSS had the best sensitivity. Further studies are required to validate the PTA as a screening metric for ectasia.
Copyright © 2018 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30115298     DOI: 10.1016/j.jcrs.2018.05.013

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  Could the percent tissue altered (PTA) index be considered as a unique factor in ectasia risk assessment?

Authors:  Carlos Rocha-de-Lossada; José-María Sánchez-González; Rahul Rachwani-Anil; Juan-Luis García-Madrona; Federico Alonso-Aliste; Sandra Figueroa-Ardila; Elvira Colmenero-Reina
Journal:  Int Ophthalmol       Date:  2020-07-27       Impact factor: 2.031

Review 2.  Advances in Biomechanical Parameters for Screening of Refractive Surgery Candidates: A Review of the Literature, Part III.

Authors:  Majid Moshirfar; Mahsaw N Motlagh; Michael S Murri; Hamed Momeni-Moghaddam; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019

3.  Validity of percentage tissue altered as a screening formula for post laser-assisted in-situ keratomileusis ectasia in Indian eyes.

Authors:  Karan Bhatia; Aniket Shastri; Deepak Mishra; K V Satyamurthy; Ruchita Manaktala; Renuka Rati
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

Review 4.  Ectasia After Corneal Refractive Surgery: A Systematic Review.

Authors:  Majid Moshirfar; Alyson N Tukan; Nour Bundogji; Harry Y Liu; Shannon E McCabe; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Ophthalmol Ther       Date:  2021-08-20

5.  Corneal epithelial remodeling after femtosecond laser-assisted in situ keratomileusis combined with intraoperative accelerated corneal collagen crosslinking for myopia: a retrospective study.

Authors:  Junjie Piao; Shen Wang; Ye Tao; Yue Hua Zhou; Ying Li
Journal:  BMC Ophthalmol       Date:  2022-08-20       Impact factor: 2.086

6.  Ectasia after keratorefractive surgery: Analysis of risk factors and treatment outcomes in the Indian population.

Authors:  B Soundarya; Gitansha Shreyas Sachdev; Shreyas Ramamurthy; Ramamurthy Dandapani
Journal:  Indian J Ophthalmol       Date:  2020-06       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.